recent reports literature tell huge crisis overtaken drug research placebos becoming effective researchers know placebos inert said getting effective answer contained articles like one walsh et al appeared april issue jama entitled placebo response studies major depression variable substantial growing authors paper meta analysis studies drug treatments major depressive disorder mdd published criteria inclusion studies meta analysis papers must published english published january december studies primarily composed outpatients major depressive disorder bipolar least patients placebo group lasted least weeks randomly assigned patients receive antidepressant drug drugs placebo assessed patients double blind conditions reported total number patients assigned placebo medication groups well number responded treatment determined reduction least score hamilton rating scale depression hrsd clinical global impression cgi rating markedly moderately improved cgi score results regression curves depicted scatter plot shown response placebo studies varied time placebo response increased average per decade going interestingly placebo response went time frame drug response went nearly rate placebo response noted studies included meta analysis patients allowed take concomitant medications mostly benzodiazepines insomnia anxiety throughout studies unfortunately common practice antidepressant trials tends confound results since sleeping better swing person hrsd score points average hsrd score patients studies also worth noting trials meta analysis allowed one two week placebo run period eliminate placebo responders period subjects given placebo anyone improves placebo run phase removed study group way skew results favor drug reduce placebo scores obviously work well walsh meta analysis years old recent studies found results except drug response go fast placebo response example report khan et al found average difference drug placebo published antidepressant trials gone average points hrsd points k antidepressants considered meet clinical usefulness standards set national institute health clinical excellence less point hrsd difference drug placebo well known meta analysis kirsch et al found ssris improved hrsd score patients points placebo rising placebo response rates seen crisis pharma industry psych meds runaway best sellers impedes approval new drugs huge amounts money line january paper american journal psychiatry columbia university bret r rutherford steven p roose try find explanations mysterious rise placebo response rates causal factors came shown increase placebo response decrease placebo response strength evidence study sites fewer study sites strong poor rater blinding good rater blinding strong multiple active treatment arms single active treatment arm strong lower probability receiving placebo higher probability receiving placebo strong single baseline rating multiple baseline ratings medium briefer duration illness current episode longer duration illness current episode medium study visits fewer study visits medium recruited volunteers self referred patients weak optimistic enthusiastic clinicians pessimistic neutral clinicians weak rutherford roose psychiatry jan factors discussed rutherford roose one potential explaining rise placebo response way volunteers recruited studies study participants mostly unpaid inpatients today paid outpatients recruited via advertising days past studies conducted mostly universities research hospitals today almost outsourced cros contract research organizations attract clientele via web radio magazine newspaper advertising often cro study volunteers people without medical insurance looking make extra money getting free medical care boot happy tell doctors whatever want hear well known drug trials hard time getting enough sign ups mentioned ben goodacre bad pharma well irving kirsch emperor new drugs creates incentive initial assessment interviewers score marginal volunteers borderline meeting minimum hsrd scores depression liberally get study enough degrade signal disastrously studies look difference antidepressant placebo kirsch others shown drug placebo differences relatively faint hard detect less severely depressed patients across large number different antidepressant types new old brings rather embarrassing point antidepressants anywhere near effective drug companies would think one squint hard distinguish effects placebo fact drug industry placebo crisis telling says meds talking powerful nothing like say insulin diabetes whatever underlying causes placebo crisis drug companies consider real troubling willing usual whatever takes make problem go away includes interesting new kinds salami slicing area experimental protocol design tomorrow blog look efforts patent dodgy protocol designs buy books click find least added name mailing list